SCHEMBL1665690

SCHEMBL1665690

Cc1ccc(-c2cn3nc(Cl)ccc3n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.56
RAB9A P51151 8/20 0.56
SMN1; SMN2 Q16637 8/20 0.56
ALDH1A1 P00352 7/20 0.56
KDM4E B2RXH2 6/20 0.56
KMT2A Q03164 4/20 0.56
MEN1 O00255 3/20 0.56
MITF O75030 2/20 0.56
PAX8 Q06710 2/20 0.56
KDM5A P29375 1/20 0.56
KDM5C P41229 1/20 0.56
TP53 P04637 6/20 0.50
MAPT P10636 5/20 0.50
GAA P10253 3/20 0.50
HPGD P15428 3/20 0.50
HSD17B10 Q99714 2/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50
ALDH1A3 P47895 3/20 0.49
SLC2A1 P11166 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22614984 0.87 NPC1 (0.57) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
Bromide SCHEMBL1691891 0.85 NPC1 (0.56) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL2544254 0.84 RAB9A (0.47) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL1395044 0.84 DRD2 (0.49) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL2540879 0.84 SMN1; SMN2 (0.41) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL3108835 0.83 NPC1 (0.54) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL10533395 0.82 NPC1 (0.57) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL1743706 0.82 DYRK1A (0.54) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL19327435 0.81 HDAC6 (0.52) NPC1RAB9AALDH1A1KDM4EKMT2A
SCHEMBL4921911 0.80 APP (0.41) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891042-B1 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA SA (BE) 2013-10-02 EP disclosed
EP-2308870-A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses UCB Pharma S.A. (BE) 2011-04-13 EP disclosed
EP-2308867-A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses UCB Pharma S.A. (BE) 2011-04-13 EP disclosed